Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) traded up 0.9% during mid-day trading on Friday . The company traded as high as €30.75 and last traded at €30.62. 1,225,487 shares were traded during trading, The stock had previously closed at €30.36.
Bayer Aktiengesellschaft Stock Performance
The company has a 50-day moving average of €27.82 and a 200-day moving average of €27.13. The stock has a market cap of $30.78 billion, a price-to-earnings ratio of -34.97, a PEG ratio of 36.39 and a beta of 0.97.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Articles
- Five stocks we like better than Bayer Aktiengesellschaft
- How to Invest in Small Cap Stocks
- Power On: Applied Digital’s First AI Data Center Goes Live
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Alphabet: The AI Leader Best Positioned to Dominate 2026
- Most Volatile Stocks, What Investors Need to Know
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
